• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒感染患者中耐氟康唑念珠菌的口咽携带率

Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.

作者信息

Martins M D, Lozano-Chiu M, Rex J H

机构信息

Department of Internal Medicine, University of Texas Medical School, Houston, USA.

出版信息

Clin Infect Dis. 1997 Oct;25(4):843-6. doi: 10.1086/515554.

DOI:10.1086/515554
PMID:9356799
Abstract

To estimate the prevalence of both clinically evident and asymptomatic carriage of fluconazole-resistant Candida, we prospectively surveyed 128 adults infected with human immunodeficiency virus (HIV). The patients had an average CD4 cell count of 206/mm3. Ninety-seven isolates of Candida were obtained from the oropharynx of 82 patients (64%). Of these 82 patients, 76% carried C. albicans alone; 18%, both albicans and non-albicans isolates; and 6%, non-albicans species alone. Oropharyngeal candidiasis was evident in only 38 (46%) of the 82 patients for whom a culture was positive and was never seen unless C. albicans was present. When MICs were measured by using the National Committee for Clinical Laboratory Standards M27-T methodology and grouped by using recently proposed breakpoints, we found that eight of the 38 patients with oropharyngeal candidiasis and six of the 44 patients who were asymptomatically colonized carried C. albicans isolates resistant to fluconazole (MIC, > or = 64 micrograms/mL); estimated rates of carriage were 21% (95% confidence interval, 10%-37%) and 14% (95% confidence interval, 5%-27%), respectively. Carriage of resistant isolates of C. albicans by HIV-infected adults is more common than previously suspected, and clinicians should be alert to the possible need for either higher doses of fluconazole or alternative treatment modalities.

摘要

为评估耐氟康唑念珠菌临床显性感染及无症状携带的患病率,我们对128例感染人类免疫缺陷病毒(HIV)的成人进行了前瞻性调查。这些患者的平均CD4细胞计数为206/mm³。从82例患者(64%)的口咽部获得了97株念珠菌分离株。在这82例患者中,76%仅携带白色念珠菌;18%同时携带白色念珠菌和非白色念珠菌分离株;6%仅携带非白色念珠菌。在82例培养阳性的患者中,仅38例(46%)有口咽部念珠菌病,且除非有白色念珠菌存在,否则从未见过口咽部念珠菌病。当采用美国国家临床实验室标准委员会M27 - T方法测定最低抑菌浓度(MIC)并根据最近提出的断点进行分组时,我们发现,38例口咽部念珠菌病患者中有8例以及44例无症状定植患者中有6例携带对氟康唑耐药的白色念珠菌分离株(MIC,≥64微克/毫升);估计携带率分别为21%(95%置信区间,10% - 37%)和14%(95%置信区间,5% - 27%)。HIV感染成人中白色念珠菌耐药分离株的携带情况比之前怀疑的更为常见,临床医生应警惕可能需要更高剂量的氟康唑或其他替代治疗方式。

相似文献

1
Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者中耐氟康唑念珠菌的口咽携带率
Clin Infect Dis. 1997 Oct;25(4):843-6. doi: 10.1086/515554.
2
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.在接受氟康唑治疗的口咽念珠菌病的人类免疫缺陷病毒感染患者中,白色念珠菌被都柏林念珠菌取代。
J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002.
3
Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.在人类免疫缺陷病毒感染患者中,口咽念珠菌病发病率和白色念珠菌携带率的下降与耐氟康唑白色念珠菌携带率降低的趋势相关。
Clin Infect Dis. 1998 Nov;27(5):1291-4. doi: 10.1086/515006.
4
Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients.HIV感染患者中耐氟康唑念珠菌菌株引起口咽定植或感染发展的决定因素。
Eur J Clin Microbiol Infect Dis. 2000 Aug;19(8):593-601. doi: 10.1007/s100960000323.
5
Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.台湾南部地区 HIV 感染门诊患者的口咽酵母定植:CD4 计数、依非韦伦治疗和静脉吸毒很重要。
Clin Microbiol Infect. 2012 May;18(5):485-90. doi: 10.1111/j.1469-0691.2011.03655.x. Epub 2011 Sep 21.
6
Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.人类免疫缺陷病毒感染患者口咽酵母菌定植的易患因素:一项前瞻性横断面研究。
J Microbiol Immunol Infect. 2013 Apr;46(2):129-35. doi: 10.1016/j.jmii.2012.07.009. Epub 2012 Aug 23.
7
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.从中国南方一个感染HIV的队列中单次及随访时分离出的白色念珠菌克隆株的抗真菌药敏异质性。
J Oral Pathol Med. 2001 Jul;30(6):336-46. doi: 10.1034/j.1600-0714.2001.300603.x.
8
Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.人类免疫缺陷病毒感染儿童中白色念珠菌对克霉唑耐药性的出现:体外与临床相关性
J Clin Microbiol. 2000 Apr;38(4):1563-8. doi: 10.1128/JCM.38.4.1563-1568.2000.
9
Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.接受长期持续与间歇氟康唑治疗的HIV感染患者的口咽酵母菌群及氟康唑耐药性
AIDS. 1996 Mar;10(3):263-8. doi: 10.1097/00002030-199603000-00004.
10
The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.从人类免疫缺陷病毒(HIV)血清阳性和有感染HIV风险的血清阴性女性中分离出的口腔和阴道念珠菌菌株的念珠菌种类演变及氟康唑敏感性。
J Infect Dis. 2001 Jan 15;183(2):286-93. doi: 10.1086/317936.

引用本文的文献

1
Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.机会致病性真菌白色念珠菌中唑类抗真菌药物耐药性的分子和遗传基础。
J Antimicrob Chemother. 2020 Feb 1;75(2):257-270. doi: 10.1093/jac/dkz400.
2
The Candida albicans Inhibitory Activity of the Extract from Papaya (Carica papaya L.) Seed Relates to Mitochondria Dysfunction.番木瓜(Carica papaya L.)种子提取物对白色念珠菌的抑制活性与线粒体功能障碍有关。
Int J Mol Sci. 2017 Aug 25;18(9):1858. doi: 10.3390/ijms18091858.
3
Profile of candidiasis in HIV infected patients.
HIV感染患者的念珠菌病概况。
Iran J Microbiol. 2012 Dec;4(4):204-9.
4
Antifungals: need to search for a new molecular target.抗真菌药物:需要寻找新的分子靶点。
Indian J Pharm Sci. 2008 Jul-Aug;70(4):423-30. doi: 10.4103/0250-474X.44588.
5
Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site.通过Mcm1p结合位点对编码药物外排决定簇的MDR1进行转录调控,该调控存在于氟康唑耐药的白色念珠菌菌株中。
Eukaryot Cell. 2006 Dec;5(12):1957-68. doi: 10.1128/EC.00243-06. Epub 2006 Oct 13.
6
Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.抗逆转录病毒治疗时代HIV感染患者口腔念珠菌分离株的菌种分布及抗真菌药敏谱
Mycopathologia. 2006 Jul;162(1):45-50. doi: 10.1007/s11046-006-0032-y.
7
Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico.在墨西哥,定殖于或感染人类免疫缺陷病毒感染者及健康人的口腔念珠菌分离株。
J Clin Microbiol. 2005 Aug;43(8):4159-62. doi: 10.1128/JCM.43.8.4159-4162.2005.
8
Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system.使用MagNA Pure LC系统从具有医学重要性的酵母菌种和丝状真菌中自动提取基因组DNA。
J Clin Microbiol. 2002 Jun;40(6):2240-3. doi: 10.1128/JCM.40.6.2240-2243.2002.
9
Susceptibility profile of vaginal yeast isolates from Brazil.巴西阴道酵母菌分离株的药敏谱。
Mycopathologia. 2001;151(1):5-10. doi: 10.1023/a:1010909504071.
10
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.导致抗真菌药物耐药性的临床、细胞和分子因素。
Clin Microbiol Rev. 1998 Apr;11(2):382-402. doi: 10.1128/CMR.11.2.382.